Home » Topics » Regulatory » Patents

Patents
RSS

Array BioPharma discovers oncolytic checkpoint kinase inhibitors

Aug. 26, 2009

Novel hypoxia-inducible factor inhibitors reported by FibroGen

Aug. 25, 2009

GSK describes novel mGlu5 receptor antagonists for substance abuse

Aug. 25, 2009

Monoamine oxidase inhibitors developed as antibacterials at Ferrer

Aug. 25, 2009

Exelixis reports creation of protein kinase inhibitors as anticancer agents

Aug. 25, 2009

TRPA1 antagonists claimed as analgesics by Abbott

Aug. 25, 2009

Novartis has disclosed novel ALK inhibitors for obstructive airways diseases

Aug. 25, 2009

Novel aromatase inhibitors claimed for cancer

Aug. 24, 2009

Cannabinoid receptor ligands created for pain therapy at Purdue Pharma

Aug. 24, 2009

Wellstat Therapeutics claims compounds for treating type 2 diabetes

Aug. 24, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...